Neogen Corp (NEOG)

Neogen's stock has experienced volatility due to mixed financial results and strategic decisions. In Q1 FY2025, revenues were $217 million with a core revenue decline of 1%, attributed to foreign currency headwinds and production challenges. Q2 FY2025 showed improvements with $231 million in revenues and 3.5% core revenue growth. Q3 Fiscal Year 2026 revenue was $211.2 million, a 4.4% decrease from the prior year, but still surpassed analyst estimates. Neogen announced an agreement to sell its global Genomics business to Zoetis for $160.0 million. The company has faced operational inefficiencies, particularly in production processes and supply chain.

Neogen Corporation experiences some demand seasonality, with the first fiscal quarter historically being the lowest. The company expects lower-than-normal seasonality in the first half of its fiscal year. The adjusted EBITDA margin is anticipated to be lowest in the first quarter, with improvements expected throughout the year. Capital expenditures are typically highest in the first and second quarters, with a more weighted performance expected in the second half of the fiscal year.

Neogen Corporation is an international company focused on enhancing food and animal safety, operating in the Healthcare sector, specifically the Medical - Diagnostics & Research industry. The company is divided into two segments: Food Safety and Animal Safety. The Food Safety segment develops and markets diagnostic test kits for detecting dangerous substances in food and feed. The Animal Safety segment focuses on veterinary instruments, pharmaceuticals, vaccines, diagnostics, and genomics testing services.

Neogen Corporation has a global presence, serving over 40 countries. Its headquarters are in Lansing, Michigan, with additional facilities in the U.S. and internationally in Canada, Mexico, Brazil, the United Kingdom, Europe, India, Australia, and China. The company expanded its global footprint through its 2022 merger with 3M's Food Safety business.

Neogen has a strong brand reputation for quality and reliability in the food and animal safety sectors. However, operational inefficiencies and supply chain disruptions have posed challenges. Production inefficiencies and supply chain issues have impacted the company's ability to meet demand efficiently, particularly in the Animal Safety segment. The Food Safety segment has shown continued strength and core growth despite these hurdles.

Neogen Corporation has significant institutional ownership, with 309 institutional owners holding 221,781,603 shares as of April 7, 2026. Major institutional owners include BlackRock, Inc. and Vanguard Group Inc. Mutual Funds & ETFs hold 110.62 million common shares, representing 50.85% of shares outstanding. Insider ownership stands at 1.04% or 2.27 million shares.